Education
About Us
Working with TipRanks
Follow Us
Duality Biotherapeutics, Inc. (HK:9606)
:9606
9606 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$165.50 - HK$289.80
Previous CloseN/A
VolumeN/A
Average Volume (3M)351.88K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.58
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding88,036,260
10 Day Avg. Volume256,580
30 Day Avg. Volume351,883
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Duality Biotherapeutics, Inc. News
PremiumCompany Announcements
Duality Biotherapeutics Addresses Stock Fluctuations Post-Data Release
PremiumCompany Announcements
Duality Biotherapeutics Announces AGM and Key Resolutions for 2025
PremiumCompany Announcements
Duality Biotherapeutics Concludes Stabilization Period for Global Offering
PremiumCompany Announcements
Duality Biotherapeutics Completes Full Exercise of Over-allotment OptionOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
<0.01%
Mutual Funds
― Other Institutional Investors
99.99% Public Companies and
Individual Investors
9606 FAQ
What was Duality Biotherapeutics, Inc.’s price range in the past 12 months?
Duality Biotherapeutics, Inc. lowest stock price was HK$165.50 and its highest was HK$289.80 in the past 12 months.
What is Duality Biotherapeutics, Inc.’s market cap?
Currently, no data Available
When is Duality Biotherapeutics, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Duality Biotherapeutics, Inc.’s earnings last quarter?
Currently, no data Available
Is Duality Biotherapeutics, Inc. overvalued?
According to Wall Street analysts Duality Biotherapeutics, Inc.’s price is currently Overvalued.
Does Duality Biotherapeutics, Inc. pay dividends?
Duality Biotherapeutics, Inc. does not currently pay dividends.
What is Duality Biotherapeutics, Inc.’s EPS estimate?
Duality Biotherapeutics, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Duality Biotherapeutics, Inc. have?
Duality Biotherapeutics, Inc. has 88,036,260 shares outstanding.
What happened to Duality Biotherapeutics, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Duality Biotherapeutics, Inc.?
Currently, no hedge funds are holding shares in HK:9606
Technical Analysis
HBM Holdings Ltd.
―
Broncus Holding Corp.
―
Gushengtang Holdings Limited
―
Angelalign Technology Inc.
―
Shandong Xinhua Pharmaceutical Company Limited Class H
―